Recombinant SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) (AA 1-419) 抗体 (Fc Tag)
(1 reference)Quick Overview for Recombinant SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) (AA 1-419) 抗体 (Fc Tag) (ABIN6952664)
抗原
See all SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) 抗体抗体类型
片段
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 1-419
-
原理
- N Recombinant Monoclonal Antibody
-
特异性
- Mouse scFv fusion with human IgG1 Fc
-
产品特性
- Recombinant anti-SARS-CoV-2 Nucleoprotein Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.
-
纯化方法
- Affinity-chromatography
-
免疫原
- Recombinant Human Novel Coronavirus Nucleoprotein (N) (1-419aa) (CSB-EP3325GMY)
-
亚型
- IgG1
-
-
anti-SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) antibody
SARS-CoV N 适用: SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, FACS, IHC, FM 宿主: 兔 Polyclonal unconjugated
anti-SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) (AA 1-419) antibodySARS-CoV N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, GICA 宿主: Chimeric Chimeric 1A6 unconjugated scFv fragment Recombinant Antibody
anti-SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) antibodySARS-CoV N 适用: SARS Coronavirus (SARS-CoV) ELISA, WB 宿主: 小鼠 Monoclonal 14B3D unconjugated
anti-SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) (AA 1-419) antibody (Fc Tag,HRP)SARS-CoV N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: 小鼠 Monoclonal 1A6 Fc Tag,HRP scFv fragment Recombinant Antibody
-
-
应用备注
- ELISA:1:10000-1:50000, WB:1:500-1:5000, GICA:1:1000-1:10000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
-
: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." in: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).
-
: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." in: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).
-
- SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)
-
别名
- SARS-CoV-2 (SARS-CoV-2/ 2019-nCoV) N
-
UniProt
- P0DTC9
抗原
-
